Sandoz Makes Major Moves To Bolster Biosimilars Ahead Of Spinoff
Announces Development Partnership With Evotec And Investment In Holzkirchen Site
• By David Wallace
Sandoz is building up its biosimilars business before spinning off from Novartis • Source: Shutterstock 
